Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

These Americans Will Receive COVID Vaccines First

By Keith Speights - Dec 12, 2020 at 11:01AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Spoiler alert: The answer could vary somewhat depending on where you live.

The first COVID-19 vaccines could soon be on the way. Pfizer ( PFE -1.80% ) and Moderna ( MRNA -5.28% ) hope to win FDA emergency use authorizations (EUA) for their coronavirus vaccines this month. But which Americans will receive the vaccines first? In this Motley Fool Live video recorded on Dec. 3, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and writer Keith Speights discuss who makes this important decision and which people are likely to be at the top of the list.

Corinne Cardina: Who is going to decide which groups of people in the US receive the first doses of vaccination? Has that been worked out?

Keith Speights: That's actually a good question. I think the answer might be a little surprising to some people because if you watched the news, you've probably heard that CDC panel called the Advisory Committee on Immunization Practices has recommended some phases of which people get vaccines first.

But really the decision will be made by the individual states. While the CDC panel will make these recommendations and has made these recommendations, it's the individual states that ultimately decide. But I suspect that most states will go along with the recommended guidelines.

Phase 1a is what they're calling it, healthcare workers and nursing home residents and staff. Phase 1b would be essential workers. Phase 1c would be anyone over 65 and those with high-risk medical conditions.

I suspect, Corinne, that most states are going to agree that those priorities make sense and those individuals should receive the vaccine first. But there's always a chance that some state or multiple states could decide to do things differently.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
$53.70 (-1.80%) $0.98
Moderna, Inc. Stock Quote
Moderna, Inc.
$294.21 (-5.28%) $-16.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/02/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.